Shares of Arecor Therapeutics plc (LON:AREC – Get Free Report) hit a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 50 ($0.63) and last traded at GBX 52 ($0.66), with a volume of 3900 shares trading hands. The stock had previously closed at GBX 52.50 ($0.66).
Arecor Therapeutics Stock Performance
The business has a 50-day simple moving average of GBX 61.78 and a 200-day simple moving average of GBX 71.45. The firm has a market capitalization of £19.63 million, a PE ratio of -1.84 and a beta of -0.18. The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- P/E Ratio Calculation: How to Assess Stocks
- These 5 Energy Stocks Hedge Inflation With Growth Potential
- Conference Calls and Individual Investors
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- The Role Economic Reports Play in a Successful Investment Strategy
- DuPont’s Electronics Spinoff: The Start of Something Big
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
